Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 822.60
+15.05 (1.86%)
Aug 11, 2026, 3:30 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 157.95 billion as of August 11, 2026. Its market cap has increased by 118.76% in one year.
Market Cap
157.95B
Enterprise Value
164.10B
Revenue
16.83B
Ranking
n/a
PE Ratio
53.12
Stock Price
822.60
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 157.95B, an increase of 350,146.00%. That is a compound annual growth rate of 35.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 160.23B | 155.06% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 328.40B |
| Piramal Pharma | 278.11B |
| Eris Lifesciences | 191.56B |
| Cohance Lifesciences | 170.53B |
| NATCO Pharma | 164.18B |
| Alivus Life Sciences | 163.22B |
| Alembic Pharmaceuticals | 163.17B |
| Sudeep Pharma | 108.15B |